Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
This snip needs to be shoved in the faces of republican voters daily until Nov.
The package includes a cap on the price of insulin for seniors on Medicare, but Republicans successfully removed a $35 cap on insulin in the private market.
https://www.cnbc.com/2022/08/07/senate-passes-sweeping-climate-health-and-tax-package-putting-democrats-on-cusp-of-historic-win.html?__source=androidappshare
2 replies
= new reply since forum marked as read
= new reply since forum marked as read
https://worldpopulationreview.com/country-rankings/cost-of-insulin-by-country
Very short: (emphasis mine)
The price of insulin in the United States compared to other countries
A landmark study published by the RAND Corporation in 2020 analyzed the average price of several different forms of insulin (human, analog, rapid, rapid-intermediate, short, short-intermediate, intermediate, and long-acting) in 33 countries of the Organization for Economic Cooperation and Development (OECD), which includes most of the world's developed countries and high-income countries. The study revealed that the manufacturer price for any given type of insulin averaged five to ten times higher in the U.S. ($98.70 USD) than in all other OECD countries ($8.81 on average). Even when using net prices, which incorporate possible rebates, U.S. prices would be roughly four times higher than in other countries.
Uncle Pennybags wins again!
Very short: (emphasis mine)
The price of insulin in the United States compared to other countries
A landmark study published by the RAND Corporation in 2020 analyzed the average price of several different forms of insulin (human, analog, rapid, rapid-intermediate, short, short-intermediate, intermediate, and long-acting) in 33 countries of the Organization for Economic Cooperation and Development (OECD), which includes most of the world's developed countries and high-income countries. The study revealed that the manufacturer price for any given type of insulin averaged five to ten times higher in the U.S. ($98.70 USD) than in all other OECD countries ($8.81 on average). Even when using net prices, which incorporate possible rebates, U.S. prices would be roughly four times higher than in other countries.
Uncle Pennybags wins again!